• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical observations in children after prenatal benzodiazepine exposure.

作者信息

Laegreid L

机构信息

Department of Pediatrics II, East Hospital, Gothenburg University, Sweden.

出版信息

Dev Pharmacol Ther. 1990;15(3-4):186-8. doi: 10.1159/000457644.

DOI:10.1159/000457644
PMID:1983095
Abstract

Eight children excessively exposed to benzodiazepines (BZD) in utero are described. Five of the 8 mothers admitted regular use of BZD and in 3 mothers, stored serum from early pregnancy could be analysed and found positive for BZD and its metabolite. All the children had similar dysmorphic features, in addition, 1 child had aplasia of one kidney and 2 had cleft palate. At follow-up 2 children had become microcephalic. 2 were severely mentally retarded, 5 had a mild mental retardation and only 1 was of normal intelligence. In a case-control study, 4 neonatal diagnoses of congenital malformations, in our experience characteristic of fetal BZD exposure, were chosen as inclusion criteria. In 8 of 18 cases, blood samples from early pregnancy were positive for BZD as compared to 2 of 60 control samples. An association between BZD-positive serum tests and the particular diagnoses could be demonstrated (p = 0.00006).

摘要

相似文献

1
Clinical observations in children after prenatal benzodiazepine exposure.
Dev Pharmacol Ther. 1990;15(3-4):186-8. doi: 10.1159/000457644.
2
Congenital malformations and maternal consumption of benzodiazepines: a case-control study.先天性畸形与母亲使用苯二氮䓬类药物:一项病例对照研究。
Dev Med Child Neurol. 1990 May;32(5):432-41. doi: 10.1111/j.1469-8749.1990.tb16962.x.
3
[In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].[子宫内暴露于苯二氮䓬类药物。使用劳拉西泮会有肛门闭锁风险吗?]
Encephale. 2003 Nov-Dec;29(6):553-9.
4
Teratogenic effects of benzodiazepine use during pregnancy.
J Pediatr. 1989 Jan;114(1):126-31. doi: 10.1016/s0022-3476(89)80619-5.
5
The effects of benzodiazepine use during pregnancy and lactation.孕期及哺乳期使用苯二氮䓬类药物的影响。
Reprod Toxicol. 1994 Nov-Dec;8(6):461-75. doi: 10.1016/0890-6238(94)90029-9.
6
Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.孕期使用苯二氮䓬类药物和苯二氮䓬受体激动剂:新生儿结局与先天性畸形
Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1203-10. doi: 10.1002/pds.1457.
7
[Benzodiazepines and pregnancy].[苯二氮䓬类药物与妊娠]
Therapie. 2000 Sep-Oct;55(5):587-95.
8
Neurodevelopment in late infancy after prenatal exposure to benzodiazepines--a prospective study.产前暴露于苯二氮䓬类药物后婴儿晚期的神经发育——一项前瞻性研究。
Neuropediatrics. 1992 Apr;23(2):60-7. doi: 10.1055/s-2008-1071314.
9
The effect of benzodiazepines on the fetus and the newborn.苯二氮䓬类药物对胎儿及新生儿的影响。
Neuropediatrics. 1992 Feb;23(1):18-23. doi: 10.1055/s-2008-1071305.
10
Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies.孕期使用苯二氮䓬类药物与重大畸形或口腔腭裂:队列研究和病例对照研究的荟萃分析
BMJ. 1998 Sep 26;317(7162):839-43. doi: 10.1136/bmj.317.7162.839.

引用本文的文献

1
Midazolam activates caspase, MAPKs and endoplasmic reticulum stress pathways, and inhibits cell cycle and Akt pathway, to induce apoptosis in TM3 mouse Leydig progenitor cells.咪达唑仑激活半胱天冬酶、丝裂原活化蛋白激酶和内质网应激途径,并抑制细胞周期和Akt途径,从而诱导TM3小鼠睾丸间质祖细胞凋亡。
Onco Targets Ther. 2018 Mar 15;11:1475-1490. doi: 10.2147/OTT.S154442. eCollection 2018.
2
Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation.孕期及哺乳期使用的抗抑郁药、抗焦虑药和催眠药。
Indian J Psychiatry. 2015 Jul;57(Suppl 2):S354-71. doi: 10.4103/0019-5545.161504.
3
Use of psychotropic drugs during pregnancy. A report of the international co-operative drug use in pregnancy (DUP) study. Collaborative Group on Drug Use in Pregnancy (CGDUP).
Eur J Clin Pharmacol. 1993;45(6):495-501. doi: 10.1007/BF00315304.